Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Thanks TechGuru. Good post as usual. One poi

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154722
(Total Views: 685)
Posted On: 10/24/2020 8:37:57 PM
Posted By: blafarm
Re: TechGuru #63064
Thanks TechGuru. Good post as usual.

One point though:

You Wrote:
Quote:
What is very encouraging is that the statistician of the DSMC considered that with 75% of patients we can probably meet statistical significance (p + power). This would indicate that we are now somewhere in the range 0.0065 - 0.016 meaning we could possible have a well-powered result with 293 patients.

I have listened to the October 20 call and recent Proactive video several times (as I always do) and can find absolutely no reference to ANYONE saying that the DSMC statistician considered that with 75% of patients we can probably meet statistical significance.

This is precisely what the DSMC communicated:
Quote:
Continue the study as planned with the protocol, defined sample size and power to achieve the primary endpoint. The DSMC recommendation was to continue the study as planned but conduct another interim analysis when 75% of the planned subjects have been randomized and have been on the study for 42 days or withdrawn, whichever occurs first. Sample size reassessment will be considered at that interim analysis.


Not only did they NOT indicate that “we can probably meet statistical significance” -- but the exact wording of what they DID say actually leaves open the possibility that the DSMC might ask for a larger sample size at 75% interim -- beyond the full enrollment protocol of 390.

I spend quite a bit of time documenting what is -- and what is not said during these calls. We are all human, but I think we get into trouble when we imprint and overlay our own wishes and desires on facts that are presented to us.


(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us